Prophylaxis of HBV recurrence with LAM monotherapy is not recommended because of the reappearance of hepatitis B surface antigen after OLT in approximately 50% of patients.

• 不推荐单独使用拉米，因为在接受原位肝移植后，大约有50%25的病人被检测出HBV表面抗原阳性；